Reconstitution Protocols for BPC-157 and TB-500 Research Peptides: Lab Best Practices
Research Use Only Disclaimer: All protocols on this page are intended strictly for use in licensed preclinical laboratory research. BPC-157 and TB-500 are not approved by the FDA for human or veterinary use. This guide is for laboratory scientists handling research-grade compounds under appropriate institutional protocols. Nothing here constitutes medical advice.
Reconstitution Protocols for BPC-157 and TB-500 Research Peptides: Lab Best Practices
Last Updated: April 3, 2026
Proper reconstitution is one of the most critical — and most commonly mishandled — steps in peptide research. A peptide that is incorrectly reconstituted may yield inconsistent experimental results, degraded compound, or inaccurate concentration calculations that undermine entire experimental runs. This guide covers best practices for reconstituting BPC-157 and TB-500 in a research laboratory setting.
For storage guidance before and after reconstitution, see our companion article on Storage and Stability Guidelines for BPC-157 and TB-500 Lyophilized Research Peptides. For purity verification standards to assess before reconstituting, see Third-Party Testing and Purity Standards for Research-Grade TB-500 and BPC-157.
Why Reconstitution Protocols Matter in Peptide Research
Lyophilized peptides are freeze-dried — all moisture has been removed to maximize stability during storage. Before they can be used in any in vitro or in vivo research preparation, they need to be dissolved back into solution. This process is called reconstitution.
Several variables in reconstitution can directly impact your research:
- Solvent choice affects peptide stability, pH compatibility with cell media, and in vivo tolerability in animal models
- Agitation method affects whether the peptide dissolves cleanly or denatures through mechanical stress
- Concentration accuracy directly determines dosing accuracy in your experimental design
- Contamination risk at this step can introduce variables that confound downstream results
Getting each of these right is not complicated, but it does require following a defined protocol consistently.
Materials You Will Need
Before beginning reconstitution of either BPC-157 or TB-500, ensure you have:
- Lyophilized peptide vial (verify identity, lot number, and purity certificate prior to opening)
- Appropriate solvent (see solvent selection section below)
- Sterile 1 mL or 3 mL syringe with a low-dead-volume tip
- Sterile needle (typically 23-25 gauge for vial penetration)
- Alcohol swabs
- A laminar flow hood or biosafety cabinet for sterile preparation
- Aliquot vials (low-binding microcentrifuge tubes or glass vials) if preparing multiple aliquots
- Labeling materials: lot number, concentration, date of reconstitution, initials
Solvent Selection: BPC-157 vs TB-500
BPC-157 Solvent Options
BPC-157 is highly water-soluble and reconstitutes readily in aqueous solvents. The recommended options for research are:
Sterile Bacteriostatic Water (0.9% benzyl alcohol): The most common choice for multi-dose vials in rodent in vivo studies. Benzyl alcohol acts as a preservative that inhibits microbial growth, extending the usable life of reconstituted peptide when refrigerated. This is the standard choice for most in vivo preclinical protocols.
Sterile Water for Injection (WFI): Suitable for single-dose preparations. No preservative means faster potential microbial growth if the vial is accessed multiple times, but avoids any potential benzyl alcohol interaction if this is a concern for your specific model.
Sterile 0.9% Saline (Normal Saline): Also suitable for BPC-157. Physiological pH and tonicity make it well-tolerated in rodent in vivo models. Some researchers prefer saline for subcutaneous or intraperitoneal routes in rodent studies.
For in vitro cell culture: Use sterile PBS (phosphate-buffered saline) to prepare a stock solution, then dilute into your cell culture medium. Avoid adding bacteriostatic water directly to cell culture due to benzyl alcohol cytotoxicity at higher concentrations.
TB-500 Solvent Options
TB-500 is also water-soluble but is a larger peptide fragment. It is slightly more prone to foaming if agitated vigorously.
Sterile Bacteriostatic Water: Recommended for in vivo rodent model preparations requiring multi-dose stability. Same considerations as BPC-157 apply.
Sterile 0.9% Saline: Suitable for TB-500. For subcutaneous or intraperitoneal routes in rodent models, saline is well-tolerated and does not require benzyl alcohol exposure.
Sterile PBS: For in vitro cell culture applications (endothelial cell migration assays, fibroblast culture, etc.), prepare stock in sterile PBS and dilute into growth medium. This avoids any osmotic disruption from bacteriostatic water.
Avoid: DMSO is not recommended for TB-500 or BPC-157 reconstitution as neither peptide requires an organic co-solvent for solubilization.
Step-by-Step Reconstitution Protocol
The following protocol applies to both BPC-157 and TB-500 unless noted otherwise.
Step 1: Preparation
Allow the lyophilized peptide vial to reach room temperature before opening. This prevents condensation from forming on the powder, which can cause clumping. Do not remove the rubber stopper.
Swab the rubber stopper with an alcohol swab and allow it to dry completely before needle insertion.
Step 2: Prepare Your Solvent Volume
Calculate the volume of solvent needed to achieve your target concentration (see Concentration Calculation section below). Draw the required volume into a sterile syringe.
Step 3: Add Solvent to the Peptide Vial
Insert the needle through the rubber stopper at an angle (not directly downward) and inject the solvent slowly down the inside wall of the vial — not directly onto the lyophilized powder cake. This gentler approach reduces foaming and ensures even wetting of the powder.
Step 4: Dissolve Without Vortexing
Do not vortex. Gently swirl or roll the vial between your palms to encourage dissolution. For BPC-157, dissolution is typically complete within 30-60 seconds with gentle mixing. For TB-500, allow 1-2 minutes of gentle rolling as the larger molecular weight peptide may take slightly longer to fully dissolve.
The solution should be clear and colorless when fully dissolved. If cloudiness persists after 2-3 minutes of gentle mixing, allow the vial to sit at room temperature for a few additional minutes before attempting further gentle agitation.
Step 5: Inspect the Solution
Before aliquoting or use, visually inspect the reconstituted peptide for particulate matter, unusual coloration, or persistent cloudiness. A properly reconstituted BPC-157 or TB-500 solution should be clear, colorless to very pale yellow, and free of visible particles.
Step 6: Aliquot If Needed
If you are preparing multiple doses for an animal study or need to store portions, prepare individual aliquots now using sterile low-binding microcentrifuge tubes. Label each aliquot with: peptide name, lot number, concentration (mg/mL or mcg/mL), reconstitution date, and your initials. Freeze aliquots not being used immediately.
Concentration Calculation Reference
The formula for reconstitution concentration is straightforward:
Concentration (mg/mL) = Peptide Mass (mg) / Volume of Solvent Added (mL)
Or rearranged to find the volume needed:
Volume of Solvent (mL) = Peptide Mass (mg) / Target Concentration (mg/mL)
Example Calculations
| Peptide Amount | Target Concentration | Solvent Volume to Add |
|---|---|---|
| 5 mg | 1 mg/mL | 5.0 mL |
| 5 mg | 0.5 mg/mL | 10.0 mL |
| 2 mg | 1 mg/mL | 2.0 mL |
| 2 mg | 0.2 mg/mL | 10.0 mL |
For very low-concentration preparations (mcg/mL range), prepare a higher-concentration stock first and dilute with additional solvent. Direct preparation of very dilute solutions from lyophilized powder is less precise.
Converting mg/mL to mcg/mL: Multiply by 1,000 (e.g., 1 mg/mL = 1,000 mcg/mL).
Post-Reconstitution Storage
Once reconstituted:
- In bacteriostatic water: Store at 2-8°C. Use within 28 days for most protocols.
- In sterile water or saline (no preservative): Use promptly or freeze in aliquots.
- For longer-term storage: Freeze aliquots at -20°C. Avoid repeated freeze-thaw of the same aliquot — plan your aliquot sizes based on single-use volumes for your experimental design.
See our full Storage and Stability Guidelines for BPC-157 and TB-500 for detailed shelf-life data and temperature excursion guidance.
Common Reconstitution Errors and How to Avoid Them
| Error | Consequence | Prevention |
|---|---|---|
| Injecting solvent directly onto powder | Foaming, incomplete dissolution | Direct solvent down the vial wall |
| Vortexing TB-500 | Foaming, potential denaturation | Gentle swirling only |
| Using wrong concentration solvent | Inaccurate dosing | Double-check calculations before adding solvent |
| Not warming vial to room temp | Condensation, clumping | Allow 10-15 min at room temperature first |
| No label on aliquots | Data integrity risk | Label every vial immediately after preparation |
| Bacteriostatic water in cell culture | Cytotoxicity | Use PBS for cell culture applications |
Sourcing Palmetto Peptides' BPC-157 and TB-500 for Your Research
Clean, accurate reconstitution begins with a high-purity starting material. Palmetto Peptides supplies both BPC-157 and TB-500 as lyophilized research peptides with third-party HPLC purity and mass spectrometry identity verification. Each lot comes with a certificate of analysis specifying sequence confirmation and purity percentage.
For guidance on evaluating research peptide suppliers more broadly, see our article on How to Source High-Purity BPC-157: What Laboratories Should Evaluate and Choosing a Trusted Supplier for TB-500 Research Peptide.
Peer-Reviewed Citations
- Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." Current Pharmaceutical Design. 2011;17(16):1612-1632.
- Goldstein AL, Hannappel E, Kleinman HK. "Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues." Trends in Molecular Medicine. 2005;11(9):421-429.
- Manning MC, et al. "Stability of protein pharmaceuticals: an update." Pharmaceutical Research. 2010;27(4):544-575. [General protein/peptide stability reference]
- Lam XM, et al. "Replacing succinate with glycolate buffer improves the stability of lyophilized interferon-gamma." International Journal of Pharmaceutics. 1996;142(1):85-95. [Lyophilization stability reference]
- Chang CH, et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." Journal of Applied Physiology. 2011;110(3):774-780.
Related Research
- BPC-157 + TB-500 Wolverine Stack Complete Guide
- BPC-157 + TB-500 Storage and Stability
- BPC-157 + TB-500 Third-Party Testing
- Sourcing High-Purity BPC-157
- Sourcing High-Purity TB-500
- Ordering BPC-157 + TB-500 Online
Frequently Asked Questions
What solvent should be used to reconstitute BPC-157 for research? BPC-157 is typically reconstituted using sterile bacteriostatic water for multi-dose stability, or sterile water for injection for single-use preparations. For cell culture, use sterile PBS.
What solvent should be used to reconstitute TB-500 for research? TB-500 reconstitutes well in sterile bacteriostatic water or sterile saline. For cell culture, use sterile PBS to avoid benzyl alcohol cytotoxicity.
How do I calculate the correct reconstitution volume for a target concentration? Divide the total peptide mass (in mg) by your target concentration (in mg/mL) to get the required solvent volume in mL.
How long is reconstituted BPC-157 or TB-500 stable after preparation? When reconstituted in bacteriostatic water and stored at 2-8°C, most research protocols use reconstituted peptides within 28 days. Aliquot and freeze for longer storage.
Should I vortex BPC-157 or TB-500 during reconstitution? No. Gentle swirling or rolling is preferred. Vortexing can cause foaming and potential denaturation, particularly with TB-500.
Disclaimer: This article is for educational and informational purposes related to preclinical laboratory research only. BPC-157 and TB-500 are not FDA-approved for human or veterinary use. Nothing here constitutes medical advice.
Part of the Wolverine Stack Research Cluster
This article is one of 15 supporting resources in the Palmetto Peptides Wolverine Stack research cluster. For the complete overview of BPC-157 and TB-500 preclinical research — including mechanisms, sourcing, handling, and legal status — return to the cluster pillar page: Palmetto Peptides Guide to the Research Peptide Stack BPC-157 and TB-500: The Wolverine Stack.
Palmetto Peptides Research Team Last Updated: April 3, 2026